Novoste To Merge With ONI Medical, Exits Once-Promising Brachy Biz
This article was originally published in The Gray Sheet
Executive Summary
Novoste will attempt to divest its Beta-Cath vascular brachytherapy (VBT) business to one of several interested parties prior to the firm's merger with ONI Medical, likely to close in the third quarter